20 Feb 2018 07:02
UDG HEALTHCARE PLC
US INVESTOR AND ANALYST EVENT
20 February 2018: UDG Healthcare plc ("the Group"), a leading international provider of healthcare services, will host a US Investor and Analyst Event today and tomorrow at the company's facilities in Allentown, Pennsylvania, USA and Fort Washington, Pennsylvania, USA. The event will include site visits and presentations from the executive and divisional management teams.
UDG Healthcare issued its first quarter trading update for the period from 1 October 2017 to 31 December 2017 on 31 January 2018 and no further material financial or trading update will be provided today or tomorrow.
Copies of the presentations will be available after the event at www.udghealthcare.com. A recording of the presentations will be made available in due course.
ENDS
For reference:
Alan Ralph CFO UDG Healthcare plc Tel: + 353-1-468-9000
| Keith Byrne Head of IR, Strategy & Corporate Communications UDG Healthcare plc Tel: + 353-1-468-9000
|
Lisa Kavanagh / Jack Hickey Powerscourt Tel: + 44-207-250-1446 |
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering commercial, clinical, communications and packaging services to the healthcare industry, employing over 9,000 people with operations in 24 countries and delivering services in over 50 countries.
UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across two broad areas of activity: commercial & clinical services, and communications services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.
Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state-of-the-art facilities in the US and Europe.
Aquilant is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.
The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.
For more information, please go to: www.udghealthcare.com